{"id":16754,"date":"2022-03-30T13:14:08","date_gmt":"2022-03-30T11:14:08","guid":{"rendered":"https:\/\/www.maiwald.eu\/?post_type=publikationen&p=16754"},"modified":"2022-03-30T13:14:09","modified_gmt":"2022-03-30T11:14:09","slug":"epo-is-there-a-doctrine-of-exhaustion-of-priority-rights-pharmaceutical-law-insight-2006-together-with-birgit-strube","status":"publish","type":"publikationen","link":"https:\/\/www.maiwald.eu\/en\/publications\/epo-is-there-a-doctrine-of-exhaustion-of-priority-rights-pharmaceutical-law-insight-2006-together-with-birgit-strube\/","title":{"rendered":"EPO: Is there a doctrine of exhaustion of priority rights, Pharmaceutical Law Insight, 2006 (together with Birgit Strube)"},"content":{"rendered":"","protected":false},"template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-16754","publikationen","type-publikationen","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/16754","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen"}],"about":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/types\/publikationen"}],"version-history":[{"count":2,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/16754\/revisions"}],"predecessor-version":[{"id":16756,"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/publikationen\/16754\/revisions\/16756"}],"wp:attachment":[{"href":"https:\/\/www.maiwald.eu\/en\/wp-json\/wp\/v2\/media?parent=16754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}